Literature DB >> 22231121

Control of the RNA polymerase II phosphorylation state in promoter regions by CTD interaction domain-containing proteins RPRD1A and RPRD1B.

Zuyao Ni1, Jonathan B Olsen, Xinghua Guo, Guoqing Zhong, Eric Dongliang Ruan, Edyta Marcon, Peter Young, Hongbo Guo, Joyce Li, Jason Moffat, Andrew Emili, Jack F Greenblatt.   

Abstract

RNA polymerase II (RNAP II) C-terminal domain (CTD) phosphorylation is important for various transcription-related processes. Here, we identify by affinity purification and mass spectrometry three previously uncharacterized human CTD-interaction domain (CID)-containing proteins, RPRD1A, RPRD1B and RPRD2, which co-purify with RNAP II and three other RNAP II-associated proteins, RPAP2, GRINL1A and RECQL5, but not with the Mediator complex. RPRD1A and RPRD1B can accompany RNAP II from promoter regions to 3'-untranslated regions during transcription in vivo, predominantly interact with phosphorylated RNAP II, and can reduce CTD S5- and S7-phosphorylated RNAP II at target gene promoters. Thus, the RPRD proteins are likely to have multiple important roles in transcription.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22231121      PMCID: PMC3265782          DOI: 10.4161/trns.2.5.17803

Source DB:  PubMed          Journal:  Transcription        ISSN: 2154-1272


  42 in total

1.  Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity.

Authors:  Huck Hui Ng; François Robert; Richard A Young; Kevin Struhl
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

2.  The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation.

Authors:  Nevan J Krogan; Jim Dover; Adam Wood; Jessica Schneider; Jonathan Heidt; Marry Ann Boateng; Kimberly Dean; Owen W Ryan; Ashkan Golshani; Mark Johnston; Jack F Greenblatt; Ali Shilatifard
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

3.  Ssu72 Is an RNA polymerase II CTD phosphatase.

Authors:  Shankarling Krishnamurthy; Xiaoyuan He; Mariela Reyes-Reyes; Claire Moore; Michael Hampsey
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

4.  Recognition of RNA polymerase II carboxy-terminal domain by 3'-RNA-processing factors.

Authors:  Anton Meinhart; Patrick Cramer
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

Review 5.  Tails of RNA polymerase II.

Authors:  J L Corden
Journal:  Trends Biochem Sci       Date:  1990-10       Impact factor: 13.807

6.  The CTD code.

Authors:  Stephen Buratowski
Journal:  Nat Struct Biol       Date:  2003-09

7.  mRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  E J Cho; T Takagi; C R Moore; S Buratowski
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

8.  Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3' end processing.

Authors:  Seong Hoon Ahn; Minkyu Kim; Stephen Buratowski
Journal:  Mol Cell       Date:  2004-01-16       Impact factor: 17.970

9.  Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II.

Authors:  Nevan J Krogan; Minkyu Kim; Amy Tong; Ashkan Golshani; Gerard Cagney; Veronica Canadien; Dawn P Richards; Bryan K Beattie; Andrew Emili; Charles Boone; Ali Shilatifard; Stephen Buratowski; Jack Greenblatt
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

10.  Structure of an mRNA capping enzyme bound to the phosphorylated carboxy-terminal domain of RNA polymerase II.

Authors:  Carme Fabrega; Vincent Shen; Stewart Shuman; Christopher D Lima
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

View more
  34 in total

Review 1.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

2.  Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.

Authors:  M Eileen Dolan; Omar El Charif; Heather E Wheeler; Eric R Gamazon; Shirin Ardeshir-Rouhani-Fard; Patrick Monahan; Darren R Feldman; Robert J Hamilton; David J Vaughn; Clair J Beard; Chunkit Fung; Jeri Kim; Sophie D Fossa; Daniel L Hertz; Taisei Mushiroda; Michiaki Kubo; Lawrence H Einhorn; Nancy J Cox; Lois B Travis
Journal:  Clin Cancer Res       Date:  2017-06-13       Impact factor: 12.531

3.  Kub5-Hera RPRD1B Deficiency Promotes "BRCAness" and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers.

Authors:  Edward A Motea; Farjana J Fattah; Ling Xiao; Luc Girard; Amy Rommel; Julio C Morales; Praveen Patidar; Yunyun Zhou; Andrew Porter; Yang Xie; John D Minna; David A Boothman
Journal:  Clin Cancer Res       Date:  2018-08-14       Impact factor: 12.531

4.  Dimerization of p15RS mediated by a leucine zipper-like motif is critical for its inhibitory role on Wnt signaling.

Authors:  Xuanzi Fan; Juan Zhao; Fangli Ren; Yinyin Wang; Yarui Feng; Lidan Ding; Linpeng Zhao; Yu Shang; Jun Li; Jianquan Ni; Baoqing Jia; Yule Liu; Zhijie Chang
Journal:  J Biol Chem       Date:  2018-04-04       Impact factor: 5.157

5.  A combinatorial view of old and new RNA polymerase II modifications.

Authors:  Danielle E Lyons; Sarah McMahon; Melanie Ott
Journal:  Transcription       Date:  2020-05-13

6.  The interactome of the atypical phosphatase Rtr1 in Saccharomyces cerevisiae.

Authors:  Whitney R Smith-Kinnaman; Michael J Berna; Gerald O Hunter; Jason D True; Peter Hsu; Gabriela I Cabello; Melanie J Fox; Gabriele Varani; Amber L Mosley
Journal:  Mol Biosyst       Date:  2014-07

7.  Crosstalk between RNA Pol II C-Terminal Domain Acetylation and Phosphorylation via RPRD Proteins.

Authors:  Ibraheem Ali; Diego Garrido Ruiz; Zuyao Ni; Jeffrey R Johnson; Heng Zhang; Pao-Chen Li; Mir M Khalid; Ryan J Conrad; Xinghua Guo; Jinrong Min; Jack Greenblatt; Matthew Jacobson; Nevan J Krogan; Melanie Ott
Journal:  Mol Cell       Date:  2019-05-01       Impact factor: 17.970

8.  CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.

Authors:  Gang Yang; Yicheng Wang; Jianchun Xiao; Fangyu Zhao; Jiangdong Qiu; Yueze Liu; Guangyu Chen; Zhe Cao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Cell Oncol (Dordr)       Date:  2020-10-30       Impact factor: 6.730

9.  Discovery of cell compartment specific protein-protein interactions using affinity purification combined with tandem mass spectrometry.

Authors:  Mathieu Lavallée-Adam; Justine Rousseau; Céline Domecq; Annie Bouchard; Diane Forget; Denis Faubert; Mathieu Blanchette; Benoit Coulombe
Journal:  J Proteome Res       Date:  2012-12-04       Impact factor: 4.466

10.  Inhibiting CREPT reduces the proliferation and migration of non-small cell lung cancer cells by down-regulating cell cycle related protein.

Authors:  Tao Liu; Wei-Miao Li; Wu-Ping Wang; Ying Sun; Yun-Feng Ni; Hao Xing; Jing-Hua Xia; Xue-Jiao Wang; Zhi-Pei Zhang; Xiao-Fei Li
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.